MindMed’s Mescaline Study Approved For Clinical Trial
Cannabis Law Report
MAY 26, 2021
MindMed (Nasdaq: MNMD) announced today that its clinical trial plans to evaluate the acute effects of serotonergic hallucinogen mescaline have… Read More.
Tryp Therapeutics Announces Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan
Cannabis Law Report
JULY 21, 2021
The study is expected to be the world’s first Phase 2a clinical trial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinical trial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.
Clinical Trials 
105
105 Join 14,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies
Cannabis Law Report
JUNE 16, 2021
Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. . This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada.
Clinical Trials 104
104 
NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials
Cannabis Law Report
JANUARY 17, 2021
The post NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials first appeared on Cannabis Law Report. We hope he does a better job than some of the playlists we’ve seen recently ! NeonMind Biosciences Inc. … Read More.
Cancer patients medicate with cannabis with or without clinical trials
Cannabis Life Network
JULY 5, 2022
Clinical evidence, however, has yet prove that cannabinoids, terpenes, or cannabis treat cancer. With or without clinical trials, though, cancer patients who medicate with cannabis remain optimistic in Canada and The Netherlands. (1, 1, 2) Before legalization in […].
Legislation To Produce And Research Cannabis Introduced
NORML
JANUARY 17, 2019
A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. Click here to send a message to your Representative and urge them to support the measure. . The agency ultimately rejected her decision.
Clinical Trials 234
234 
NORML Formally Responds to DEA’s Proposed Changes to Marijuana Cultivation Rules
NORML
APRIL 8, 2020
The National Organization for the Reform of Marijuana Laws (NORML) has formally submitted comments to the US Federal Register opposing the Drug Enforcement Administration’s proposed rule changes governing the federal production and distribution of cannabis for clinical research purposes.
Cultivation 355
355 
Ehave, Inc. ramps up to begin clinical trials by adding esteemed medical professional to its medical advisory board.
Cannabis Law Report
JUNE 29, 2021
We look forward to his expertise as we expand our mental health analytical platform and enter clinical trials. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. ramps up to begin clinical trials by adding esteemed medical professional to its medical advisory board.
Clinical Trials 105
105 
Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application
Cannabis Law Report
MAY 11, 2021
Partnership Aimed at Delivering Psychedelic Capsule for Dosing Study in Human Clinical Trial. VANCOUVER, BC, May 11, 2021 /CNW/… Read More.
IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
Cannabis Law Report
JUNE 7, 2021
IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.
InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
Puff Puff Post
MARCH 10, 2020
InMed and CHDR are currently preparing the Clinical Trial Application for a second Phase 1 clinical trial (755-102-HV), planned to begin in the second quarter of 2020, which will examine the local safety of INM-755 on small areas of wounded skin in healthy volunteers.
RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial
Cannabis Law Report
JUNE 1, 2021
The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. Los Angeles, California. www.InvestorBrandNetwork.com. 310.299.1717 Office.
FSD Pharma Inc. Announces Termination of FSD-201 Phase 2 Clinical Trial
Cannabis Law Report
AUGUST 24, 2021
Nasdaq:HUGE) (CSE:HUGE) (FRA:0K9) (the “ Company ” or “ FSD ”) announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide (“PEA”), or FSD-201, for use in treating COVID-19. TORONTO–(BUSINESS WIRE)–FSD Pharma Inc.
Cannabis laws in Japan: Is weed legal?
The Cannigma
MAY 19, 2021
Japanese authorities can prosecute citizens for violating its cannabis laws — even if they used it abroad. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes. Shutterstock).
Law 137
137 
Psilocybin lawyer asks 9th Circ to weigh workaround to fed drug law
Cannabis Law Report
SEPTEMBER 4, 2021
The clinic, the Advanced Integrative Medical Science (AIMS) Institute, asked the agency for permission to use psilocybin under Washington and federal “right to try” laws, which allow terminally ill patients to try drugs that are still under investigation. Forty-one states have passed such laws.
Clinical Trials 109
109 
Knowde Group Inc.™ Enters Into a Strategic Partnership with LMC Manna Research to Drive Quality and Collaboration in the Conduct of Cannabis and Psychedelic Clinical Trials.
Cannabis Law Report
JULY 19, 2021
There is an urgent need for objective, scientifically sound and robust clinical trials to support medicinal cannabis and psychedelics (psilocybin, MDMA, LSD, Ketamine). Collectively, between the two organizations we offer a full-service package from protocol development to timely and successful clinical trial execution.”.
Press Release: Creso Pharma’s psychedelics company cleared to start clinical trials
Cannabis Law Report
FEBRUARY 27, 2022
“Securing Clinical Trial Authorisation solidifies over 16 months of hard work and dedication from our team and positions Halucenex as one of very few Canadian companies with approval to commence a clinical trial utilising psychedelic substances on mental health conditions,” president, CEO and founder Bill Fleming said.
Justice Department Urged To Take “Immediate Action” On Marijuana Grow Applications
NORML
MARCH 1, 2019
.” He later acknowledged that these restrictions have led many “companies [to] go overseas to conduct research with foreign-grown product that is more easily sourced for the purposes of clinical trials.” ” Although that ruling ordered DEA to lift the ban, the agency failed to do so.
DEA 199
199 
FDA Issues First Guidance on Clinical Trials for Psychedelic Drugs
Cannabis Law Report
JUNE 30, 2023
Food and Drug Administration (FDA or Agency) on June 23, 2023, released its first draft guidance concerning design and desired features of clinical trials for psychedelic drugs LSD and MDMA There has been growing interest in studying the use of psychedelic drugs for […]
Chanelle McCoy Granted Approval For Significant Ultra Pure Synthetic CBD Phase III Efficacy Clinical Trial
Cannabis Law Report
JANUARY 11, 2023
PRESS RELEASE UK company Chanelle McCoy Health granted Ethics Approval to commence Phase III Efficacy Clinical Trial for the treatment of Sleep Disturbance CMH-CBD-001 using their Ultra Pure Synthetic Cannabinoid (CBD) formulation with pharmaceutical grade FDA registered raw material.
Filament administers psilocybin to 14 participants in Health Canada sanctioned clinical trial
Cannabis Law Report
SEPTEMBER 2, 2022
The clinical trial involving the use of Filament’s psilocybin received approval from Health Canada and was conducted as part of ATMA Journey Centre’s psychedelic-assisted therapist training program. Filament administers psilocybin to 14 participants in Health Canada sanctioned clinical trial.
Press Release: Creso Pharma’s (ASX:CPH) subsidiary Halucenex handed dealer’s license
Cannabis Law Report
AUGUST 15, 2021
Creso Pharma’s (CPH) subsidiary, Halucenex, is being awarded a dealer’s licence in Canada, allowing it to advance its clinical trial plans. Halucenex says the licence allows it to progress its planned phase two clinical trial of psilocybin on treatment-resistant post-traumatic stress disorder.
Clinical Trials 105
105 
Director of Funder Engagement
Cannabis Law Report
NOVEMBER 2, 2020
About Psychedelic Science Funders Collaborative: Psychedelic Science Funders Collaborative (PSFC), a 501(c)(3) nonprofit, supports research on and clinical trials of physician-prescribed psychedelic medicines and patient … Read More. The post Director of Funder Engagement first appeared on Cannabis Law Report.
With $20M to spend on marijuana research for veteran care, Michigan seeks proposals
Cannabis Law Report
JUNE 2, 2021
Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. None of it was initially slated to go to clinical trials. The deadline for proposals is Friday, July 16. Read more at.
Clinical Trials 105
105 
Peter Reynolds Article: The Desperate Rearguard Action the British Medical Establishment is Fighting Against Cannabis
Cannabis Law Report
AUGUST 7, 2021
I have a particular interest in epidemiology and clinical trials and in particular running clinical trials in childhood epilepsy.”. It’s hardly surprising then that in such a pre-eminent position, his opinion on the use of medical cannabis in paediatric epilepsy is regarded as if it had the force of law amongst doctors.
Press Release: Silo Pharma Secures Patent that May be Used for Psychedelics Delivery Technology
Cannabis Law Report
AUGUST 22, 2021
Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Presently, the company is working with researchers to build out these technologies and pave the way for clinical trials. Silo Pharma Inc. Looking to the Future. Silo Pharma Inc.
Clinical Trials 105
105 
The Scott of Pot At It Again. Cann Group aiming for over-the-counter CBD approval in late 2022
Cannabis Law Report
AUGUST 23, 2021
Phase I clinical trial of the Satipharm CBD capsules in which results demonstrated the safety and high performance of the oral capsule technology, including the superior delivery profile of cannabidiol (CBD) compound to trial subjects. Here’s the mindless blurb.
Clinical Trials 105
105 
New Frontiers in the Law of Psychedelics
Cannabis Law Report
JULY 9, 2021
The state of the law on psychedelic substances is in flux. Some of the most promising substances, and the law applicable to each, are outlined below: Psilocybin. As such, the use, sale, and possession of psilocybin in the United States is illegal under federal law. have also passed “Right to Try” laws.
Law 81
81 
‘The Doors are Wide Open’: Denver Cannabis Company Gets DEA Approval To Expand Alzheimer’s Research
Cannabis Law Report
JULY 23, 2021
“When you’re talking about wanting to do an actual clinical trial, you need a diversity of people that participate and one state just does not have the diversity of people that are required,” Towle said. The new DEA research license will now change that.
DEA 105
105 
This Psilocybin Patent Could Be a Really Big Deal
Canna Law Blog
JANUARY 22, 2020
The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post back in 2018. In that post, I explained how the Food and Drug Administration (FDA) approval process works and why this trial is so interesting and important. Psilocybin!
Clinical Trials 140
140 
A Bipartisan Bill Is Pledging $75 Million for Psychedelic Research in Military PTSD Treatment
Veriheal
JULY 18, 2023
Clinical Trials and Reporting The bill breaks new ground by allowing clinical trials to take place regardless of whether the tested substances fall under federal or military statutes. This opens up unprecedented possibilities for conducting research without the typical constraints imposed by substance classifications.
Treatment 98
98 
Press Release: Biomind Labs Announces the Start of the First-Ever Clinical Trial Targeting Depression and Anxiety in Alzheimer’s Disease With a Proprietary formulation Based On 5-MeO-DMT
Cannabis Law Report
APRIL 28, 2023
(“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by targeting the drivers of disease, is pleased to announce that it has commenced a Phase II clinical trial for its proprietary […] (..)
Gaize’s Virtual Reality Headset Can Tell if You’re Too High to Drive or Work Safely
Veriheal
JANUARY 11, 2023
Not only this, but Gaize recently completed the largest clinical trial into cannabis impairment , and the results are set to transform the realm of workplace and road safety. How do you feel about this being the largest cannabis impairment clinical trial ever? Does Gaize plan on carrying out any future clinical trials?
Cannabis 3.0 Accelerates Access to Consumer and Medical Research
Cannabis Law Report
DECEMBER 27, 2019
Virtual Clinical Trials transcend geographic, mobility and economic barriers. Clinical trials are medical research projects involving human participants. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies.
Cannabis laws in Jordan
The Cannigma
MAY 9, 2023
Medical: illegal Recreational: illegal Cannabis laws in Jordan have been a controversial topic in recent years. However, enforcement of cannabis laws in Jordan has been inconsistent in the past. However, in 2019, the Jordanian government announced its plans to conduct clinical trials on the use of cannabis for medical purposes.
Law 52
52 
European Regulatory Lead MAPS PBC Santa Cruz, CA
Cannabis Law Report
AUGUST 7, 2021
The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. The right candidate will have a passion for clinical research in novel therapeutics and a proven track record of regulatory affairs experience. Key Responsibilities.
Clinical Trials 105
105 
Cybin Announces Closing of Overnight Marketed Public Offering of Common Shares and Exercise of Over-Allotment Option
Cannabis Law Report
AUGUST 3, 2021
state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. Securities Act and applicable state securities laws. Except as required by law, the Company does not intend to update these forward-looking statements. Securities Act or under any U.S. About Cybin.
Clinical Trials 105
105 
Ketamine One Advances Research Capabilities via Controlled Substance Dealers Licence Application
Cannabis Law Report
JULY 28, 2021
The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable Clinical Trials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinical trials in the areas of psychedelics and nutraceuticals, among other substances of study.
Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA™ COVID-19 Vaccine Candidate in Felines
Cannabis Law Report
APRIL 12, 2021
– Vaccine Candidate Well Tolerated and Effective in Cohort – – Strong Neutralizing Antibody Titer Elicited Across Cohort – STONY… Read More.
Weekly Legislative Roundup 1/4/19
NORML
JANUARY 4, 2019
Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. Click here to email your member of Congress and urge them to join the Cannabis Caucus. MA resident? New Hampshire.
Legislation 128
128 
Creso Announce To ASX: Creso Pharma completes acquisition of established Canadian psychedelics company Halucenex Life Sciences Inc
Cannabis Law Report
JULY 15, 2021
Halucenex to progress phase II clinical trial to test the efficacy of psilocybin when used to treat Post Traumatic Stress Disorder (PTSD). ? Halucenex’s operation progress continues – USP 61 test protocols complete providing additional validation of psilocybin compounds ahead of Clinical Trial Application. ?
Press Release: Global Wellness Signs Definitive Agreement with Cannvalate Australia
Cannabis Law Report
AUGUST 10, 2021
This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. (“Shanti”), and all its assets focused on psychedelic MDMA-based drug development. from 2020 to 2030 and generate revenue of $151.7
Chronic Pain 105
105 
Harvard Law School Announces the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
Cannabis Law Report
JULY 1, 2021
The Project on Psychedelics Law and Regulation (POPLAR). The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Background. The Project.
Law 59
59 
Let's personalize your content